1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
(
- Contribution to journal › Article
- 2022
-
Mark
Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy after Acute Ischemic Stroke in Atrial Fibrillation (TIMING) : A Registry-Based Randomized Controlled Noninferiority Study
(
- Contribution to journal › Article
-
Mark
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS) : Protocol for a randomized controlled trial
(
- Contribution to journal › Article
- 2020
-
Mark
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
(
- Contribution to journal › Article
- 2018
-
Mark
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
(
- Contribution to journal › Article
- 2017
-
Mark
Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation : Study protocol for a registry-based randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Transient ischemic attack and ischemic stroke patients with or without prior stroke
(
- Contribution to journal › Article
- 2016
-
Mark
Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke : A Swedish Stroke Register (Riksstroke) Study
(
- Contribution to journal › Article
-
Mark
Overcoming global challenges in stroke prophylaxis in atrial fibrillation : The role of non-vitamin K antagonist oral anticoagulants
(
- Contribution to journal › Scientific review